pageleftimg products
pagebanner products
imgfollow

ABV-1501 Triple Negative Breast Cancer

▌ Indication
    Combination therapy for Triple Negative Breast Cancer (TNBC)

▌ Safety
    ABV-1501 has been used for more than 10 years as functional food

▌ Status
    Q1, 2016 IND approval for phase II trial from US FDA, TFDA.

▌ Patent
    Granted in US, GB, JP, DE, FR, IT, CN

▌ Cancer-cell implanted mice treated with chemotherapy
    Enhancement of anti-tumor activity and reduction of
    chemotherapy-induced side effects

▌ Non-randomized human studies
    Amelioration of chemotherapeutic side effects

▌ Phase I/II study on breast cancer patients
    No dose-limiting toxicity encountered

▌ Phase II study on MDS patients
    Enhancement of ROS respiratory burst activity

Copyright © American BriVision Corporation . All rights reserved. Design BY NOYAINC